As the world aspires to return to a better life after the epidemic, countries are rushing to provide vaccines that should reduce – and hope to prevent – the spread of corona virus.
The success of this process depends on a number of factors, from the production and transfer of billions of doses, to the extent that rich nations do not govern themselves A global vaccine, and, seriously, is gaining traction in human hands.
The charts and maps below have been updated to reflect the latest developments regarding the largest vaccine in history, in the US and around the world.
There are significant differences between countries and countries in which vaccines are actively distributed to the general population.
The first vaccine approved because emergency use in the US, manufactured by companies Pfizer / BioNTech and Modern, was scheduled for two doses a few weeks later. The program of Johnson & Johnson The vaccine approved for use in late February requires only one dose. Therefore, each vaccination in the US will ultimately mean providing between 100 and 200 doses per 100 people in each region and region – or between 330 million and 660 million of the total. I am a serious material problem.
Vaccination in the US began to slow down more than expected. Trump officials have set a goal of giving 20 million vaccines by the end of 2020. This goal was not achieved until the end of January. Earlier in March, President Joe Biden said the US would have enough vaccines for all officials at the end of May – two months earlier than his supervisors had planned. However, there are concerns that the vaccine is causing poverty people and areas of color back.
Check or navigate to this table to see how your community or region is performing on the main vaccine components.
Time to vaccinate
This chart shows the number of vaccines given to 100 people in each state since the beginning of 2021. The top three countries with US numbers are shown. Enter the name of each region or US segment in the search bar and select add to the chart.
This chart shows the number of daily vaccines given to people throughout the region since early 2021. Because of the spikes in the data due to a lack of disclosure, the line showing the seven days of delivery provides a clear indication of whether discharge is slowing down or slowing down.
COUNTRY OF ORIGIN
Vaccination by country
Many countries can be found on the map showing the vaccine given to 100 people because these numbers are so well known.
The US is ahead of the rest of the world in developing vaccines. But of the great nations Israel has always been the first leader.
Search or navigate this table to see how each country is moving. It reveals that other countries have taken a different approach: The UK, for example, decided to give as many people as possible a start, and delayed their second shot.
Time to vaccinate
This chart shows the number of vaccines given to 100 people in each country since early 2021. Write the name of each tribe in the search and choose to compare its time with the US and the other top three leading vaccines worldwide. Only countries that have begun their vaccine efforts will appear.
This chart shows the number of daily vaccines given to people around the world. Because of the spikes due to the residual in the description, the 7-day line of the given type gives a clear indication as to whether the output is speeding or delaying.
Conditional vaccination status
This table lists some of the leading COVID-19 vaccines, showing patents for use in the US and other selected markets, including information prices on the purchase agreement written by UNICEF, where available.
Vaccines from Pfizer / BioNTech and Moderna, and the results of clinical trials than 90% effective in the prevention of disease, it is based on new technology which provides the sequence RNA that triggers our cells to release viral proteins, which triggers the immune system.
The simple fact is that the vaccine is much more expensive than those produced by genetically modified organisms from coronavirus into other disabled species, such as those produced by the Anglo-Sweden company AstraZeneca, based on an Oxford University study, Johnson & Johnson, and Russia Gamaleya Research Institute.
Some advanced vaccines are based on an inactive form of coronavirus, a long-acting vaccine, or small groups of proteins from the virus.
Jeremy Singer-Vine provided reports on the matter.